The latest news:

• Patient Foundation Collaboration to Advance ONC201 in DIPG and other H3 K27M-mutant Gliomas        

   This project will speed up the development of a drug (Onc-201) that has shown promise in early trials for DIPG as well as high grade gliomas that have a specific mutation called H3 K27m. If you have DIPG or a high grade glioma with that mutation, give us a call.

   This is a one million dollar grant, to be paid in 4 equal payments over the next 3 years. We gave the first $250,000 payment today!  I am going to need help raising the rest of the money!  This is one of the most important projects that we have ever worked on and we need to raise the money for the next payment in a few months.  Contact us for details.  
  




• NCI and Musella Foundation Award Grants for ONC201 Trials in Adult and Pediatric Brain Tumors         I would like to emphasis that this is a collaboration between the Musella Foundation, the Cure Starts Now Foundation, and the Michael Mosier Defeat DIPG Foundation! we couldn't have done this without them. 

   
  




• Optune Open House: St. Louis, MO         These are nice meetings for anyone who has a brain tumor or cares for someone with a brain tumor
  



• KKCO - Daybreak Anchor Sarah Schwabe's Connection To Glioblastoma         A video segment about glioblastoma
  

BrainTumor Co-Payment Assistance Program Status:

• Almost closed to new applicants - Call first